Inverse agonism gains weight

被引:73
作者
Adan, RAH [1 ]
Kas, MJH [1 ]
机构
[1] Univ Utrecht, Med Ctr, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3584 CG Utrecht, Netherlands
关键词
D O I
10.1016/S0165-6147(03)00130-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inverse agonism is emerging as a new endogenous principle for receptor regulation. Agouti-related protein (AgRP), following its release in the brain, stimulates food intake. AgRP binds to brain melanocortin receptors, which are involved in the regulation of body weight. In addition to antagonizing the effects of the melanocortin receptor agonist alpha-melanocyte-stimulating hormone (alpha-MSH), AgRP suppresses the constitutive activity of melanocortin MC3 and MC4 receptors, which characterizes AgRP as an inverse agonist rather than a neutral antagonist. The balance between the activity of AgRP-containing neurons and alpha-MSH-containing neurons determines the extent of activation of melanocortin receptors in neurons onto which they project. The identification of AgRP as an endogenous inverse agonist provides physiological relevance to inverse agonism in the control of body weight.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 43 条
[1]   A polymorphism in the human agouti-related protein is associated with late-onset obesity [J].
Argyropoulos, G ;
Rankinen, T ;
Neufeld, DR ;
Rice, T ;
Province, MA ;
Leon, AS ;
Skinner, JS ;
Wilmore, JH ;
Rao, DC ;
Bouchard, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4198-4202
[2]   Effects of leptin and corticosterone on the expression of corticotropin-releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse [J].
Arvaniti, K ;
Huang, OL ;
Richard, D .
NEUROENDOCRINOLOGY, 2001, 73 (04) :227-236
[3]  
Bagnol D, 1999, J NEUROSCI, V19
[4]   The genetics of pigmentation: From fancy genes to complex traits [J].
Barsh, GS .
TRENDS IN GENETICS, 1996, 12 (08) :299-305
[5]   Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28 [J].
Casarosa, P ;
Bakker, RA ;
Verzijl, D ;
Navis, M ;
Timmerman, H ;
Leurs, R ;
Smit, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1133-1137
[6]   Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential [J].
Daeffler, L ;
Landry, Y .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (02) :73-87
[7]   Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery [J].
de Ligt, RAF ;
Kourounakis, AP ;
Ijzerman, AP .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :1-12
[8]   NEOMORPHIC AGOUTI MUTATIONS IN OBESE YELLOW MICE [J].
DUHL, DMJ ;
VRIELING, H ;
MILLER, KA ;
WOLFF, GL ;
BARSH, GS .
NATURE GENETICS, 1994, 8 (01) :59-65
[9]   Antagonist and agonist activities of the mouse Agouti protein fragment (91-131) at the melanocortin-1 receptor [J].
Eberle, AN ;
Bódi, J ;
Orosz, G ;
Süli-Vargha, H ;
Jäggin, V ;
Zumsteg, U .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2001, 21 (01) :25-45
[10]  
FAN W, 2002, 5 MEL M SUNR OR